| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |